Outpace Bio

formerly Outpace

AI-Powered Protein Design for Cell Therapy

Seattle, United States · Founded 2020 · $174.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$174.0M
Last Round
$144.0M Series BAug 2024
Rounds
2

About

Outpace Bio is a Seattle-based biotechnology company using AI-powered protein design to develop next-generation cell therapies targeting solid tumors. Its platform combines de novo protein engineering with cellular engineering to improve the efficacy and safety of CAR-T and other cell therapy products. Founded in 2020, the company raised a $144M Series B in 2024.

Summary

Outpace Bio is an Artificial Intelligence company based in Seattle, United States, founded in 2020. It has raised $174.0M in total across 2 rounds, most recently a $144.0M Series B round in Aug 2024.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2024
$144.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Outpace Bio on Indexed.vc
<a href="https://indexed.vc/companies/outpace-bio"><img src="https://indexed.vc/api/badge/company/outpace-bio" alt="Outpace Bio on Indexed.vc" width="260" height="76" /></a>